Biochemical Diagnosis of Genetic Disorders

On this page

Introduction & Screening - Spotting Trouble Early

  • Biochemical diagnosis: Identifies genetic disorders by detecting abnormal metabolites or altered enzyme activities.
  • Primary Goal: Early detection for timely intervention, improving prognosis and quality of life.
  • Screening Approaches:
    • Newborn Screening (NBS):
      • Population-wide, uses dried blood spots (DBS).
      • Detects common, treatable Inborn Errors of Metabolism (IEMs) pre-symptomatically.
    • Prenatal Screening:
      • For high-risk pregnancies (e.g., family history, advanced maternal age).
      • Uses amniocentesis, Chorionic Villus Sampling (CVS) for fetal analysis.
  • Key Techniques: Enzyme assays, chromatography, mass spectrometry (especially MS/MS).

⭐ Tandem mass spectrometry (MS/MS) has revolutionized newborn screening, allowing for the simultaneous detection of over 50 metabolic disorders from a single dried blood spot.

Diagnostic Approaches & Techniques - Unmasking Defective Pathways

  • Goal: Identify biochemical defects (metabolites, enzyme function) to confirm genetic disorders.
  • Specimens:
    • Blood: Plasma, serum, leukocytes, RBCs, dried blood spots (DBS).
    • Urine: For organic acidurias, mucopolysaccharidoses (MPS).
    • CSF: Neurotransmitter disorders.
    • Tissue Biopsy: Fibroblasts, liver, muscle (enzyme assays, EM).
  • Key Techniques:
    • Chromatography: TLC (sugars, amino acids); HPLC (amino acids, organic acids).
    • Mass Spectrometry (MS):
      • Tandem MS (MS/MS): Core of Newborn Screening (NBS); detects multiple analytes for aminoacidopathies, organic acidemias, FAO defects.
    • Enzyme Assays: Direct measurement of enzyme activity in cells/tissues.
    • Electrophoresis: Hb variants, proteins.
    • Molecular (DNA/RNA): PCR, Sequencing (Sanger, NGS) for mutation detection; MLPA for deletions/duplications.

⭐ Gas Chromatography-Mass Spectrometry (GC-MS) is the gold standard for identifying and quantifying abnormal organic acids in urine, crucial for diagnosing organic acidemias.

Major Disorder Categories & Markers - Biochemical Fingerprints

  • Aminoacidopathies:
    • PKU: ↑ Phenylalanine (Phe), ↓ Tyrosine. Mousy odor.
    • MSUD: ↑ BCAAs (Leu, Ile, Val). Maple syrup odor. 📌 I Love Vermont.
    • Homocystinuria: ↑ Homocysteine.
    • Tyrosinemia I: ↑ Succinylacetone.
  • Organic Acidemias:
    • Propionic/Methylmalonic: ↑ Propionylcarnitine; ↑ Methylmalonic acid (MMA).
    • Isovaleric: ↑ Isovalerylglycine. Sweaty feet odor.
  • Urea Cycle Defects (UCDs):
    • All: ↑ NH3 (Ammonia).

    ⭐ In Urea Cycle Defects like OTC deficiency, markedly elevated ammonia and orotic acid in urine (due to mitochondrial carbamoyl phosphate overflow into pyrimidine synthesis) are key diagnostic pointers, distinguishing it from CPS-I deficiency.

  • Lysosomal Storage Disorders (LSDs):
    • Enzyme deficiencies; substrate accumulation (e.g., Tay-Sachs: Hex A↓, GM2↑).
  • Carbohydrate Disorders:
    • Galactosemia: ↑ Gal-1-P.
    • HFI: ↑ Fru-1-P.
  • Mitochondrial Disorders:
    • ↑ Lactate, ↑ Pyruvate; ↑ Lactate/Pyruvate ratio.

High‑Yield Points - ⚡ Biggest Takeaways

  • Newborn screening (NBS) is crucial for early detection of treatable disorders like PKU.
  • Enzyme assays directly measure deficient enzyme activity in disorders like Tay-Sachs.
  • Metabolite analysis (urine/blood) identifies abnormal accumulations in aminoacidopathies and organic acidemias.
  • Tandem Mass Spectrometry (MS/MS) is the cornerstone of modern expanded NBS.
  • Molecular genetic testing (DNA analysis) provides definitive diagnosis and carrier detection.
  • Prenatal diagnosis using CVS or amniocentesis allows for early fetal biochemical/genetic assessment.

Practice Questions: Biochemical Diagnosis of Genetic Disorders

Test your understanding with these related questions

The following cost-effective investigations are routinely recommended in the screening of antenatal mothers, EXCEPT:

1 of 5

Flashcards: Biochemical Diagnosis of Genetic Disorders

1/10

_____ is due to defect in the metabolism of leucine following branched chain metabolism (BCKDH)

TAP TO REVEAL ANSWER

_____ is due to defect in the metabolism of leucine following branched chain metabolism (BCKDH)

Isovaleric aciduria

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial